Chimeric antigen receptors targeting sialyl lewis a and uses thereof

JP7672340B2Active Publication Date: 2025-05-07MEMORIAL SLOAN KETTERING CANCER CENT +1
2 Cites 0 Cited by

Patent Information

Application Number
JP2021547039
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2018-10-19
Filing Date
2019-10-18
Publication Date
2025-05-07
Estimated Expiration
2039-10-18
Patent Text Reader

Abstract

The presently disclosed subject matter provides methods and compositions for treating cancer (e.g., pancratic cancer). The presently disclosed subject matter relates to antigen-recognizing receptors (e.g., chimeric antigen receptors (CARs)) that specifically target sialyl Lewis A (e.g., human sialyl Lewis A) and immunoresponsive cells comprising such CARs. The presently disclosed sialyl Lewis A-specific CARs have enhanced immune activation properties, including anti-tumor activity. The presently disclosed subject matter provides methods and compositions for treating cancer (e.g., pancreatic cancer).
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Nucleic acid encoding a human antibody against sialyl-Lewis a

    JP2016534735A

  • Treatment of cancer using chimeric antigen receptors

    JP2017513818A